|
(PQB-2) ""Driver"" vs. ""passenger"" epigenetic events in Ewing sarcoma
|
1R01CA183776-01
|
$309,175
|
$309,175
|
LESSNICK, STEPHEN
|
UNIVERSITY OF UTAH
|
|
00000000; D.GUY; SEVERABLE OPERATIONS FOR NCI-FREDERICK
|
261200800001E
|
$296,673,020
|
$79,794
|
Heimbrook, David
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
A mouse model for human gastrointestinal stromal tumor
|
5R01CA102774-10
|
$363,278
|
$363,278
|
BESMER, PETER
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
A new radiopharmaceutical for the treatment of metastatic bone cancer
|
5R44CA150601-03
|
$701,849
|
$701,849
|
SIMON, JAIME
|
ISOTHERAPEUTICS GROUP, LLC
|
|
A novel functional genomic pipeline for target identification in sarcoma
|
1R21CA187516-01
|
$211,451
|
$211,451
|
AMATRUDA, JAMES
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$225,712
|
$67,713
|
Tosato, Giovanna
|
CCR (NCI)
|
|
A role for notch in self renewal in embryonal rhabdomyosarcoma
|
1K99CA175184-01A1
|
$180,360
|
$180,360
|
IGNATIUS, MYRON
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-38S1
|
$74,997
|
$3,750
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-38
|
$7,449,701
|
$372,485
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Addressing Herpesvirus-associated Cancers through the UNC-Malawi Cancer Consortiu
|
1U54CA190152-01
|
$697,934
|
$376,884
|
GOPAL, SATISH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Adoptive T cell Therapy for Patients with NY-ESO-1 Expressing Sarcomas
|
5K23CA175167-02
|
$171,720
|
$171,720
|
POLLACK, SETH
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
3U01CA121947-08S1
|
$6,300,000
|
$1,575,000
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
5U01CA121947-08
|
$1,900,000
|
$475,000
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,360,387
|
$68,019
|
Oberholtzer, J.
|
CCR (NCI)
|
|
Angiogenin-induced RNA cleavage in cancer
|
5R01CA168872-02
|
$346,327
|
$173,164
|
ANDERSON, PAUL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
ZIA SC 004020
|
$2,416,689
|
$120,834
|
Berzofsky, Jay
|
CCR (NCI)
|
|
ATP-Dependent Chromatin Remodeling in Human Malignancy
|
5R01CA163915-03
|
$317,818
|
$238,364
|
CRABTREE, GERALD
|
STANFORD UNIVERSITY
|
|
Autophagy and Apoptosis in the Response of c-KIT Cancers to Targeted Therapy
|
5K08CA154782-05
|
$143,362
|
$71,681
|
GORDON, PETER
|
UNIVERSITY OF MINNESOTA
|
|
Axl receptor signaling in MPNST; potential node for therapy
|
5K08CA160443-03
|
$170,618
|
$170,618
|
TORRES, KEILA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S1
|
$75,000
|
$1,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S3
|
$48,834
|
$977
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S4
|
$149,801
|
$2,996
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-08
|
$2,746,741
|
$54,935
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda
|
1U54CA190146-01
|
$700,000
|
$343,000
|
CASPER, COREY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Biological Implications and Translational Applications of HDMX Inhibition
|
ZIA BC 011261
|
$48,625
|
$19,450
|
Bernal, Federico
|
CCR (NCI)
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$358,240
|
$71,648
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Biostatistics and Data Management Section
|
ZID SC 007202
|
$557,103
|
$27,855
|
Steinberg, Seth
|
CCR (NCI)
|
|
Bone and Soft Tissue Tumor Etiology: Role and Function of TRE17/USP6
|
5R01CA168452-02
|
$258,230
|
$129,115
|
CHOU, MARGARET
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Cancer Center Core Support Grant
|
3P30CA016086-38S1
|
$75,000
|
$4,500
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
3P30CA016086-38S3
|
$11,838
|
$710
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
3P30CA016086-38S4
|
$149,896
|
$8,994
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
5P30CA016086-38
|
$6,597,984
|
$395,879
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support (Core) Grant
|
5P30CA014051-43
|
$3,738,697
|
$186,935
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-39S1
|
$74,957
|
$1,499
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-39S2
|
$50,000
|
$1,000
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-39S3
|
$120,000
|
$2,400
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-39S4
|
$150,002
|
$3,000
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
5P30CA016672-39
|
$10,086,149
|
$201,723
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support Grant
|
2P30CA013696-40
|
$3,596,904
|
$35,969
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-40S1
|
$125,000
|
$1,250
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-40S2
|
$50,000
|
$500
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-40S3
|
$320,000
|
$3,200
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-40S4
|
$75,000
|
$750
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA016087-34S2
|
$75,000
|
$750
|
CARROLL, WILLIAM
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Cancer Center Support Grant
|
3P30CA016087-34S3
|
$134,749
|
$1,347
|
CARROLL, WILLIAM
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Cancer Center Support Grant
|
5P30CA016087-34
|
$2,352,696
|
$23,527
|
CARROLL, WILLIAM
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Cancer Center Support Grant
|
3P30CA016058-38S1
|
$75,000
|
$750
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-38S2
|
$125,000
|
$1,250
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-38S3
|
$135,233
|
$1,352
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-38S4
|
$149,838
|
$1,498
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
Total relevant funding to Sarcoma for this search: $71,995,071
|